Medical consultants, PC

Muncie, Indiana 47303

0 studies enrolling now · 40 studies all time

What they study most

Acute Coronary Syndrome, Acute Myocardial Infarction (AMI), Anti-coagulation Therapy, Atherosclerosis, Atrial Fibrillation, B-Cell Chronic Lymphocytic Leukemia, Breast Cancer, Cancer, Cardiovascular Disease, Congestive Heart Failure, Coronary Artery Disease, Coronary Occlusion

Studies at this site

• Cardiovascular Inflammation Reduction Trial — Completed
• A Study to Evaluate the Effect of Long-term Treatment With BELVIQ (Lorcaserin HCl) on the Incidence of Major Adverse Cardiovascular Events and Conversion to Type 2 Diabetes Mellitus in Obese and Overweight Subjects With Cardiovascular Disease or Multiple Cardiovascular Risk Factors — Completed
• Study Of The Effectiveness & Safety Of Lenalidomide Versus Chlorambucil As First Line Therapy For Elderly Patients With B-Cell CLL (The ORIGIN Trial) — Completed
• AngelMed for Early Recognition and Treatment of STEMI — Completed
• A Phase II Study of Bevacizumab + Sorafenib in Metastatic Breast Cancer — Stopped early
• Azacitidine and Erythropoietin Versus Azacitidine Alone for Patients With Low-Risk Myelodysplastic Syndromes — Stopped early
• Sutent + Taxol for Advanced Esophageal Cancer — Completed
• Pemetrexed Plus Cetuximab in Patients With Recurrent Non Small Cell Lung Cancer — Completed
• A Biological Sample Collection Protocol of Women With and Without Breast Cancer — Completed
• Pemetrexed as Second-Line Therapy in Treating Patients With Hormone Refractory Prostate Cancer — Completed
• Cisplatin/Etoposide/Radiotherapy Followed by Consolidation Sorafenib for Inoperable Stage III Non-Small Cell Lung Cancer — Stopped early
• Study To Evaluate D-Ribose For The Treatment of Congestive Heart Failure — Withdrawn before enrolling
• Capecitabine + Irinotecan Followed by Combined Modality Capecitabine and Radiation in Locally Advanced Rectal Cancer — Stopped early
• Pemetrexed and Radiation for Poor-Risk Stage III Non-Small Cell Lung Cancer — Stopped early
• Aprepitant + a 5HT3 + Dexamethasone in Patients With Germ Cell Tumors — Completed
• Cisplatin/Etoposide/Radiotherapy +/- Consolidation Docetaxel in Advanced Stage III Non-Small Cell Lung Cancer — Completed
• Sorafenib + Topotecan for Platinum-Resistant Recurrent Ovarian Cancer — Stopped early
• Imatinib Mesylate in Combination With Docetaxel for Advanced, Platinum-Refractory Ovarian Cancer — Completed
• Erlotinib in Combination With Docetaxel in Advanced Hepatocellular and Biliary Tract Carcinomas — Stopped early
• Erlotinib + Bevacizumab for PS 2 Chemotherapy Naïve Non-Small Cell Lung Cancer — Completed
• Phase III Acute Coronary Syndrome — Stopped early
• Amrubicin + Cyclophosphamide in Advanced Solid Organ Malignancies — Completed
• Capecitabine and Oxaliplatin in Treating Patients With Metastatic Breast Cancer — Completed
• PTK787 + Trastuzumab for HER2 Overexpressing Metastatic Breast Cancer — Stopped early
• Warfarin Adverse Event Reduction For Adults Receiving Genetic Testing at Therapy INitiation (WARFARIN) — Paused
• Velcade,Thalidomide, and Dexamethasone Versus Velcade and Dexamethasone Versus Velcade, Melphalan, and Prednisone — Completed
• DORADO-AC - Optimized Doses of Darusentan as Compared to an Active Control in Resistant Hypertension — Completed
• DORADO-AC-EX - A Long-Term Safety Extension Study to the Phase 3 DORADOC-AC Study (Protocol DAR-312) of Darusentan in Resistant Hypertension — Stopped early
• APRiCOT-P: Study of Apricoxib With Gemcitabine and Erlotinib to Treat Advanced Pancreatic Cancer — Completed
• Intravenous Palifosfamide-tris in Combination With Etoposide and Carboplatin in Patients With Malignancies — Status unconfirmed
• APRiCOT-B: Study to Evaluate Apricoxib in Combination With Lapatinib and Capecitabine in the Treatment of HER2/Neu+ Breast Cancer (TP2001-202) — Stopped early
• Ibutilide Administration During Pulmonary Vein Ablation — Status unconfirmed
• Biorepository: Indiana Health Study — Status unconfirmed
• Docetaxel and Capecitabine for First Line Treatment of Metastatic Squamous Cell Carcinoma of the Head & Neck — Stopped early
• Capecitabine, Oxaliplatin and Trastuzumab in Treating Patients With HER2 Positive Metastatic Breast Cancer — Stopped early
• A Study of Paclitaxel Plus Bevacizumab in Patients With Chemosensitive Relapsed Small Cell Lung Cancer — Completed
• Pemetrexed in Patients With Chemosensitive and Chemoresistant Relapsed Small Cell Lung Cancer — Stopped early
• Non-small Cell Lung Cancer Registry — Completed
• XIENCE V® EXCEED: Evaluation of XIENCE V® Catheterization Lab Endpoints and Excellence in Delivery — Completed
• Study of TLK286 (Telcyta) vs. Gefitinib in Locally Advanced or Metastatic Non-Small Cell Lung Cancer — Completed